%0 Journal Article
%T Intussusception in a term newborn with duct-dependent congenital heart disease
%A Banu Ayd£¿n
%A Dilek Dilli
%A Ay£¿eg¨¹l Zenciro£¿lu
%A Derya Erdo£¿an
%J Dicle Medical Journal
%D 2013
%I Dicle University Medical School
%X Prostaglandin E1 infusion is widely used to maintain patencyof ductus arteriosus in newborns with duct-dependentcongenital heart disease until surgery. ProstaglandinE1 is a lifesaving drug, but it has many side effects includingfever, apnea, bradycardia, hypotension, convulsion,edema, and cortical hyperostosis. The gastrointestinaltract has not been recognized as a major site of seriousadverse effects of prostaglandin E1 infusion, althoughdiarrhea is a well-recognized side effect that usually respondsto dose reduction. In this report, we present acase of intestinal intussusception presumably induced byprostaglandin therapy in a newborn with duct-dependentcongenital heart disease.Key words: Prostaglandin E1, newborn, gastrointestinal
%K Key words: Prostaglandin E1
%K newborn
%K gastrointestinal
%U http://www.diclemedj.org/upload/sayi/26/Dicle%20Med%20J-01190.pdf